Valor202020212022202320242025TTMGastos comerciales, generales y administrativos167.3 M142.1 M111.6 M477.1 M709.7 M755.8 M755.8 MInvestigación y desarrollo357.7 M540.1 M322.9 M408 M481 M550 M550 MBeneficio operativo593.6 M555.9 M979.7 M1.18 B1.38 B1.49 B1.49 BTotal de ingresos no operativos45.3 M38 M-29.1 M89.4 M162 M221.4 M221.4 MGastos por intereses, netos de intereses capitalizados23.5 M18.6 M32.4 M59.3 M42.9 M19.5 M19.5 MIngresos no operativos, una vez deducidos los gastos por intereses-27.5 M-22.8 M-21.3 M44.1 M113.3 M153 M153 MIngresos/gastos extraordinarios49.3 M42.2 M-40.2 M-14 M5.8 M48.9 M48.9 MBeneficio antes de impuestos638.9 M593.9 M950.6 M1.27 B1.54 B1.71 B1.71 BParticipación en los beneficios———————Impuestos124.1 M118.1 M223.3 M289.5 M343.9 M379.2 M379.2 MParticipación minoritaria———————Otros ingresos/gastos después de impuestos47 M-65.9 M-52.5 M4.9 M24.3 M19.7 M19.7 MBeneficio neto antes de actividades interrumpidas514.8 M475.8 M727.3 M984.8 M1.2 B1.33 B1.33 BOperaciones suspendidas———————Beneficio neto514.8 M475.8 M727.3 M984.8 M1.2 B1.33 B1.33 BAjuste por dilución———————Dividendos de las acciones preferentes———————Beneficio neto diluido atribuible a los accionistas514.8 M475.8 M727.3 M984.8 M1.2 B1.33 B1.33 BBeneficio básico por acción11.6510.615.9821.0426.4430.1330.13Beneficio por acción diluido11.5410.061519.8124.6427.8627.86Número medio de acciones ordinarias44.2 M44.9 M45.5 M46.8 M45.2 M44.3 M178.1 MAcciones diluidas44.6 M47.3 M48.5 M49.7 M48.5 M47.9 M192.1 MEBITDA643.5 M605.8 M1.03 B1.24 B1.45 B1.58 B1.58 BEBIT593.6 M555.9 M979.7 M1.18 B1.38 B1.49 B1.49 BCosto de los ingresos108.1 M122.5 M151.6 M257.5 M309.7 M384.4 M384.4 MOtros costes de producción———————Amortización y depreciación (flujo de caja)49.9 M49.9 M51.3 M53.2 M72.5 M85.6 M85.6 M
United Therapeutics Corporation - Common Stock
United Therapeutics Corporation is an American biotechnology company that develops pharmaceuticals and technologies related to organ transplantation, including xenotransplantation. Many of the company's products are focused towards lung disease and organ manufacturing. United Therapeutics is co-headquartered in Silver Spring, Maryland and Research Triangle Park, North Carolina, with additional facilities in Magog and Bromont, Quebec; Melbourne and Jacksonville, Florida; Blacksburg, Virginia; and Manchester, New Hampshire.